Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

NCT01598896 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT01598896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01598896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
Lead sponsor
Mclean Hospital
Phase
Phase 2/3
Overall status
Terminated
Start date
May 31, 2012
Completion date
August 31, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis dependence, marijuana dependence